The debate highlighted that mitochondrial transfer could be therapeutic, but raised concerns about whether mitochondria from AD or other neurodegenerative disease contexts retain dysfunction. This fundamental question determines whether enhancing transfer is beneficial or harmful. Source: Debate session sess_sda-2026-04-01-gap-v2-89432b95 (Analysis: sda-2026-04-01-gap-v2-89432b95)
Landscape Summary: Do transferred mitochondria from diseased astrocytes carry pathological damage that could harm recipient neurons? is a 0.9 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: partially_addressed.
Colonna, Sevlever, et al. (TREM2 biology)
Do transferred mitochondria from diseased astrocytes carry pathological damage that could harm recipient neurons? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No knowledge graph edges recorded
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: